Literature DB >> 21921141

HCaRG accelerates tubular repair after ischemic kidney injury.

Hiroyuki Matsuda1, Julie L Lavoie, Louis Gaboury, Pavel Hamet, Johanne Tremblay.   

Abstract

The repair of the kidney after ischemia/reperfusion injury involves proliferation of proximal tubular epithelial cells as well as cell migration and differentiation. Immediately after reperfusion, expression of hypertension-related calcium-regulated gene (HCaRG/COMMD5) decreases, but its expression increases even higher than baseline during repair. HCaRG inhibits proliferation and accelerates wound healing and differentiation in cultured cells, but whether HCaRG can stimulate renal repair after ischemia/reperfusion injury is unknown. Here, transgenic mice overexpressing human HCaRG survived longer and recovered renal function faster than littermate controls after ischemia/reperfusion (64% versus 25% survival at 7 days). Proliferation of proximal tubular epithelial cells stopped earlier after ischemia/reperfusion injury, E-cadherin levels recovered more rapidly, and vimentin induction abated faster in transgenic mice. HCaRG overexpression also reduced macrophage infiltration and inflammation after injury. Taken together, these data suggest that HCaRG accelerates repair of renal proximal tubules by modulating cell proliferation of resident tubular epithelial cells and by facilitating redifferentiation.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21921141      PMCID: PMC3279999          DOI: 10.1681/ASN.2010121265

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  48 in total

Review 1.  Growth and death in the developing mammalian kidney: signals, receptors and conversations.

Authors:  Jonathan B L Bard
Journal:  Bioessays       Date:  2002-01       Impact factor: 4.345

2.  Differential expression patterns of claudins, tight junction membrane proteins, in mouse nephron segments.

Authors:  Yumiko Kiuchi-Saishin; Shimpei Gotoh; Mikio Furuse; Akiko Takasuga; Yasuo Tano; Shoichiro Tsukita
Journal:  J Am Soc Nephrol       Date:  2002-04       Impact factor: 10.121

3.  Dissection of key events in tubular epithelial to myofibroblast transition and its implications in renal interstitial fibrosis.

Authors:  J Yang; Y Liu
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

Review 4.  Update on mechanisms of ischemic acute kidney injury.

Authors:  Prasad Devarajan
Journal:  J Am Soc Nephrol       Date:  2006-05-17       Impact factor: 10.121

5.  Role of the increase in p21 in cisplatin-induced acute renal failure in rats.

Authors:  Takehiko Miyaji; Akihiko Kato; Hideo Yasuda; Yoshihide Fujigaki; Akira Hishida
Journal:  J Am Soc Nephrol       Date:  2001-05       Impact factor: 10.121

6.  Systemic administration of naked plasmid encoding hepatocyte growth factor ameliorates chronic renal fibrosis in mice.

Authors:  J Yang; C Dai; Y Liu
Journal:  Gene Ther       Date:  2001-10       Impact factor: 5.250

7.  Positive effect of the induction of p21WAF1/CIP1 on the course of ischemic acute renal failure.

Authors:  J Megyesi; L Andrade; J M Vieira; R L Safirstein; P M Price
Journal:  Kidney Int       Date:  2001-12       Impact factor: 10.612

8.  Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice.

Authors:  R L Davisson; Y Ding; D E Stec; J F Catterall; C D Sigmund
Journal:  Physiol Genomics       Date:  1999-07-15       Impact factor: 3.107

9.  TNF-alpha mediates chemokine and cytokine expression and renal injury in cisplatin nephrotoxicity.

Authors:  Ganesan Ramesh; W Brian Reeves
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

10.  Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury.

Authors:  Won K Han; Veronique Bailly; Rekha Abichandani; Ravi Thadhani; Joseph V Bonventre
Journal:  Kidney Int       Date:  2002-07       Impact factor: 10.612

View more
  6 in total

1.  New mouse model of chronic kidney disease transitioned from ischemic acute kidney injury.

Authors:  Jin Wei; Jie Zhang; Lei Wang; Shan Jiang; Liying Fu; Jacentha Buggs; Ruisheng Liu
Journal:  Am J Physiol Renal Physiol       Date:  2019-05-22

Review 2.  Mouse model of ischemic acute kidney injury: technical notes and tricks.

Authors:  Qingqing Wei; Zheng Dong
Journal:  Am J Physiol Renal Physiol       Date:  2012-09-19

3.  Genome-Wide Association of CKD Progression: The Chronic Renal Insufficiency Cohort Study.

Authors:  Afshin Parsa; Peter A Kanetsky; Rui Xiao; Jayanta Gupta; Nandita Mitra; Sophie Limou; Dawei Xie; Huichun Xu; Amanda Hyre Anderson; Akinlolu Ojo; John W Kusek; Claudia M Lora; L Lee Hamm; Jiang He; Niina Sandholm; Janina Jeff; Dominic E Raj; Carsten A Böger; Erwin Bottinger; Shabnam Salimi; Rulan S Parekh; Sharon G Adler; Carl D Langefeld; Donald W Bowden; Per-Henrik Groop; Carol Forsblom; Barry I Freedman; Michael Lipkowitz; Caroline S Fox; Cheryl A Winkler; Harold I Feldman
Journal:  J Am Soc Nephrol       Date:  2016-10-11       Impact factor: 10.121

4.  Blocking cell cycle progression through CDK4/6 protects against chronic kidney disease.

Authors:  Yosuke Osaki; Marika Manolopoulou; Alla V Ivanova; Nicholas Vartanian; Melanie Phillips Mignemi; Justin Kern; Jianchun Chen; Haichun Yang; Agnes B Fogo; Mingzhi Zhang; Cassianne Robinson-Cohen; Leslie S Gewin
Journal:  JCI Insight       Date:  2022-06-22

Review 5.  Hypertension-related, calcium-regulated gene (HCaRG/COMMD5) and kidney diseases: HCaRG accelerates tubular repair.

Authors:  Hiroyuki Matsuda; Pavel Hamet; Johanne Tremblay
Journal:  J Nephrol       Date:  2014-02-11       Impact factor: 3.902

6.  HCaRG/COMMD5 inhibits ErbB receptor-driven renal cell carcinoma.

Authors:  Hiroyuki Matsuda; Carole G Campion; Kyoko Fujiwara; Jin Ikeda; Suzanne Cossette; Thomas Verissimo; Maiko Ogasawara; Louis Gaboury; Kosuke Saito; Kenya Yamaguchi; Satoru Takahashi; Morito Endo; Noboru Fukuda; Masayoshi Soma; Pavel Hamet; Johanne Tremblay
Journal:  Oncotarget       Date:  2017-05-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.